Kenvue Inc. (NYSE:KVUE) Position Boosted by Sunbelt Securities Inc.

Sunbelt Securities Inc. boosted its position in Kenvue Inc. (NYSE:KVUE) by 31.7% in the 1st quarter, Holdings Channel reports. The institutional investor owned 22,413 shares of the company’s stock after buying an additional 5,391 shares during the period. Sunbelt Securities Inc.’s holdings in Kenvue were worth $481,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Kenvue by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 148,880,588 shares of the company’s stock valued at $3,205,399,000 after acquiring an additional 2,226,390 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Kenvue by 19.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 109,327,221 shares of the company’s stock valued at $2,353,816,000 after purchasing an additional 18,118,056 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Kenvue by 6.7% in the 4th quarter. Wellington Management Group LLP now owns 76,501,956 shares of the company’s stock worth $1,647,087,000 after buying an additional 4,815,126 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Kenvue by 9.1% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 66,665,454 shares of the company’s stock valued at $1,435,307,000 after buying an additional 5,574,265 shares during the period. Finally, Morgan Stanley grew its position in shares of Kenvue by 4,057.4% during the 3rd quarter. Morgan Stanley now owns 31,162,614 shares of the company’s stock valued at $625,745,000 after buying an additional 30,413,040 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of recent research reports. Citigroup reissued a “neutral” rating and issued a $21.00 target price on shares of Kenvue in a report on Tuesday, May 28th. HSBC boosted their price objective on Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Sanford C. Bernstein began coverage on Kenvue in a research note on Thursday, April 11th. They set an “underperform” rating and a $18.00 price objective for the company. William Blair assumed coverage on Kenvue in a research note on Wednesday, April 3rd. They issued a “market perform” rating on the stock. Finally, The Goldman Sachs Group began coverage on shares of Kenvue in a research report on Friday, March 1st. They set a “neutral” rating and a $20.00 price target for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $23.09.

Kenvue Stock Down 0.3 %

Kenvue stock opened at $18.59 on Thursday. Kenvue Inc. has a 52 week low of $17.75 and a 52 week high of $26.66. The stock has a market cap of $35.60 billion and a price-to-earnings ratio of 23.83. The company’s 50-day moving average price is $19.24 and its two-hundred day moving average price is $20.01. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.03. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $3.79 billion. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The company’s quarterly revenue was down 24.9% compared to the same quarter last year. On average, analysts expect that Kenvue Inc. will post 1.17 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.30%. The ex-dividend date was Tuesday, May 7th. Kenvue’s dividend payout ratio is presently 102.56%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.